jRCT1090220095已完成不适用
Prospective observational study of azithromycin in patients with acute exacerbation of fibrosing interstitial pneumonia
Dividion of respiratory medicine, Saiseikai Kumamoto Hospital0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 主要终点
- -
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
入选标准
- •Clinically confirmed acute exacerbation of fibrosing interstitial pneumonia patients in japan based on the JRS diagnostic criteria for acute exacerbation of interstitial pneumonia
- •Patients with written informed consent
排除标准
- •Patients with malignancy
- •Patients who have allergy symptoms for macrolide
- •Patient with long QT syndrome or ventricular tachycardia
- •Patients who are not appropriate to participate to the trial.
结局指标
主要结局
-
60-day survival from admission
次要结局
- safety of intravenous azithromycin
研究者
相似试验
已完成
Unknown
Prospective observational study of azithromycin in patients with acute exacerbation of fibrosing interstitial pneumoniaacute exacerbation of fibrosing interstitial pneumoniaJPRN-jRCT1090220095Dividion of respiratory medicine, Saiseikai Kumamoto Hospital30
尚未招募
不适用
A retrospective study for the effects of azithromycin administration and ultrasonic scaling in patients with severe periodontitissevere periodontitisJPRN-UMIN000037439Tokyo Medical and Dental University15
已完成
3 期
The effect of azithromycin in treatment of COVID19IRCT20200415047092N1Tehran University of Medical Sciences110
进行中（未招募）
不适用
An open-label, multi-center trial of azithromycin pharmacokinetics in sinus aspirate and serum following oral administration of either a 500 mg immediate-release (IR) once-daily 3 day regimen or a single-dose 2.0g azithromycin microspheres regimen in subjects with acute bacterial sinusitis.Acute bacterial sinusitisMedDRA version: 7.1Level: LLTClassification code 10060841EUCTR2005-000639-13-FIPfizer Ltd30
进行中（未招募）
不适用
An open-label, multi-center trial of azithromycin pharmacokinetics in sinus aspirate and serum following oral administration of either a 500 mg immediate-release (IR) once-daily 3 day regimen or a single-dose 2.0g azithromycin microspheres regimen in subjects with acute bacterial sinusitis.Acute bacterial sinusitisMedDRA version: 7.1Level: LLTClassification code 10060841EUCTR2005-000639-13-SEPfizer Ltd30